{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T18:17:50Z","timestamp":1758046670891,"version":"3.44.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.pharma.2021.07.003","type":"journal-article","created":{"date-parts":[[2021,7,24]],"date-time":"2021-07-24T10:23:39Z","timestamp":1627122219000},"page":"227-237","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pratiques de curarisation\/d\u00e9curarisation et impact des modalit\u00e9s de d\u00e9curarisation sur les dur\u00e9es en salle op\u00e9ratoire et SSPI\u00a0\u2013\u00a0r\u00e9sultats d\u2019une enqu\u00eate Delphi"],"prefix":"10.1016","volume":"80","author":[{"given":"J.","family":"Raft","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Anastasy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Lambaudie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Saillio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Mackosso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Petrica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Le Dissez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Alfonsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.pharma.2021.07.003_bib0155","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/MJT.0000000000000092","article-title":"A scientific review including safety and efficacy, update on regulatory issues, and clinical use in Europe","volume":"22","author":"Jahr","year":"2015","journal-title":"Am J Ther"},{"issue":"1","key":"10.1016\/j.pharma.2021.07.003_bib0160","first-page":"57","article-title":"Residual Neuromuscular Blockade","volume":"84","author":"Plummer-Roberts","year":"2016","journal-title":"AANA J"},{"issue":"2","key":"10.1016\/j.pharma.2021.07.003_bib0165","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00000542-200502000-00005","article-title":"Impact of anesthesia management characteristics on severe morbidity and mortality","volume":"102","author":"Arbous","year":"2005","journal-title":"Anesthesiology"},{"year":"2018","series-title":"R\u00e9f\u00e9rentiel fran\u00e7ais sur la curarisation et la d\u00e9curarisation en anesth\u00e9sie [Internet]","author":"Soci\u00e9t\u00e9 Fran\u00e7aise d\u2019Anesth\u00e9sie et de R\u00e9animation (SFAR)","key":"10.1016\/j.pharma.2021.07.003_bib0170"},{"key":"10.1016\/j.pharma.2021.07.003_bib0175","series-title":"53e congr\u00e8s national d\u2019anesth\u00e9sie et de r\u00e9animation M\u00e9decins. Conf\u00e9rence d\u2019actualisation","article-title":"Curarisation, monitorage et d\u00e9curarisation [Internet]","author":"Donati","year":"2011"},{"key":"10.1016\/j.pharma.2021.07.003_bib0180","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1016\/S0750-7658(09)72487-6","article-title":"Monitorage de la curarisation et pr\u00e9vention de la curarisation r\u00e9siduelle","volume":"28","author":"Fuchs-Buder","year":"2009","journal-title":"Ann Fr Anesth Reanim"},{"issue":"3","key":"10.1016\/j.pharma.2021.07.003_bib0185","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/bja\/aeq157","article-title":"Postoperative residual curarization from intermediate-acting neuromuscular blocking agents delays recovery room discharge","volume":"105","author":"Butterly","year":"2010","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.pharma.2021.07.003_bib0190","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1016\/S0750-7658(09)72487-6","article-title":"Monitorage de la curarisation et pr\u00e9vention de la curarisation r\u00e9siduelle","volume":"28","author":"Fuchs-Buder","year":"2009","journal-title":"Ann Fr Anesthe Reanim"},{"issue":"3","key":"10.1016\/j.pharma.2021.07.003_bib0195","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/oxfordjournals.bja.a013428","article-title":"Postoperative residual curarization and evidence-based anaesthesia","volume":"84","author":"Viby-Mogensen","year":"2000","journal-title":"Br J Anaesth"},{"issue":"5","key":"10.1016\/j.pharma.2021.07.003_bib0200","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1097\/00000542-200305000-00002","article-title":"Evidence-based practice and neuromuscular monitoring: it's time for routine quantitative assessment","volume":"98","author":"Eriksson","year":"2003","journal-title":"Anesthesiology"},{"key":"10.1016\/j.pharma.2021.07.003_bib0205","unstructured":"Enqu\u00eate de pratique sur l\u2019utilisation en France des curares chez l\u2019adulte en anesth\u00e9sie - EM|consulte [Internet]. [cit\u00e9 26\u00a0mai 2020]. Disponible sur: https:\/\/www.em-consulte.com\/en\/article\/179099."},{"year":"2019","series-title":"Bridion: r\u00e9sum\u00e9 des caract\u00e9ristiques produit [Internet]","author":"Agence Europ\u00e9enne du M\u00e9dicament","key":"10.1016\/j.pharma.2021.07.003_bib0210"},{"issue":"12","key":"10.1016\/j.pharma.2021.07.003_bib0215","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1111\/anae.13277","article-title":"A systematic review of sugammadex vs neostigmine for reversal of neuromuscular blockade","volume":"70","author":"Abad-Gurumeta","year":"2015","journal-title":"Anaesthesia"},{"issue":"5","key":"10.1016\/j.pharma.2021.07.003_bib0220","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/bja\/aeq270","article-title":"Sugammadex for reversal of neuromuscular block after rapid sequence intubation: a systematic review and economic assessment","volume":"105","author":"Chambers","year":"2010","journal-title":"Br J Anaesth"},{"issue":"5","key":"10.1016\/j.pharma.2021.07.003_bib0225","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1093\/bja\/aeq269","article-title":"Sugammadex compared with neostigmine\/glycopyrrolate for routine reversal of neuromuscular block: a systematic review and economic evaluation","volume":"105","author":"Paton","year":"2010","journal-title":"Br J Anaesth"},{"issue":"3","key":"10.1016\/j.pharma.2021.07.003_bib0230","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.bja.2018.11.028","article-title":"Retrospective analysis of 30-day unplanned readmission after major abdominal surgery with reversal by sugammadex or neostigmine","volume":"122","author":"Oh","year":"2019","journal-title":"Br J Anaesth"},{"issue":"10","key":"10.1016\/j.pharma.2021.07.003_bib0235","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.annfar.2011.06.013","article-title":"Analyse des d\u00e9penses de curares et de sugammadex apr\u00e8s une ann\u00e9e d\u2019utilisation en routine clinique","volume":"30","author":"Raft","year":"2011","journal-title":"Ann Fr Anesth Reanim"},{"key":"10.1016\/j.pharma.2021.07.003_bib0240","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2147\/CEOR.S100921","article-title":"Sugammadex for reversal of neuromuscular blockade: a retrospective analysis of clinical outcomes and cost-effectiveness in a single center","volume":"8","author":"Carron","year":"2016","journal-title":"Clinicoecon Outcomes Res"},{"key":"10.1016\/j.pharma.2021.07.003_bib0245","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2147\/CEOR.S109951","article-title":"The use of sugammadex for bariatric surgery: analysis of recovery time from neuromuscular blockade and possible economic impact","volume":"8","author":"De Robertis","year":"2016","journal-title":"Clinicoecon Outcomes Res"},{"key":"10.1016\/j.pharma.2021.07.003_bib0250","doi-asserted-by":"crossref","DOI":"10.1097\/MJT.0000000000000103","article-title":"Sugammadex: a comprehensive review of the published human science, including renal studies [Internet]","author":"Partownavid","year":"2015","journal-title":"IAm J Therapeut"},{"issue":"1","key":"10.1016\/j.pharma.2021.07.003_bib0255","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12871-016-0281-3","article-title":"A discrete event simulation model of clinical and operating room efficiency outcomes of sugammadex versus neostigmine for neuromuscular block reversal in Canada","volume":"16","author":"Insinga","year":"2016","journal-title":"BMC Anesthesiol"},{"key":"10.1016\/j.pharma.2021.07.003_bib0260","doi-asserted-by":"crossref","DOI":"10.1097\/EJA.0b013e32833d56b7","article-title":"Reversal of rocuronium-induced neuromuscular blockade with sugammadex compared with neostigmine during sevoflurane anaesthesia: results of a randomised, controlled trial [Internet]","author":"Blobner","year":"2010","journal-title":"Eur J Anaesthesiol"},{"key":"10.1016\/j.pharma.2021.07.003_bib0265","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1016\/j.respe.2017.03.056","article-title":"Combien faut-il d\u2019experts dans une enqu\u00eate Delphi? \u00c9tude de simulation","volume":"65","author":"Boulkedid","year":"2017","journal-title":"Revue d\u2019\u00c9pid\u00e9miologie et de Sant\u00e9 Publique"},{"issue":"7001","key":"10.1016\/j.pharma.2021.07.003_bib0270","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1136\/bmj.311.7001.376","article-title":"Consensus methods for medical and health services research","volume":"311","author":"Jones","year":"1995","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.pharma.2021.07.003_bib0275","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s12325-015-0249-6","article-title":"Development of a consensus statement for the definition, diagnosis, and treatment of acute exacerbations of idiopathic pulmonary fibrosis using the Delphi technique","volume":"32","author":"Maher","year":"2015","journal-title":"Adv Ther"},{"issue":"1","key":"10.1016\/j.pharma.2021.07.003_bib0280","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1213\/ANE.0b013e3181c07428","article-title":"A survey of current management of neuromuscular block in the United States and Europe","volume":"111","author":"Naguib","year":"2010","journal-title":"Anesth Analg"},{"key":"10.1016\/j.pharma.2021.07.003_bib0285","unstructured":"Debaene B. Comment j\u2019utilise en pratique le monitorage de la curarisation?:11."},{"key":"10.1016\/j.pharma.2021.07.003_bib0290","article-title":"Propositions pour la prise en charge anesth\u00e9sique d\u2019un patient suspect ou infect\u00e9 \u00e0 Coronavirus COVID-19 - La SFAR [Internet]","author":"Soci\u00e9t\u00e9 Fran\u00e7aise d\u2019Anesth\u00e9sie et de R\u00e9animation (SFAR)","year":"2020","journal-title":"Soci\u00e9t\u00e9 Fran\u00e7aise d\u2019Anesth\u00e9sie et de R\u00e9animation. 2020"},{"key":"10.1016\/j.pharma.2021.07.003_bib0150","unstructured":"Dalkey N, Helmer O. An experimental application of the Delphi methode to the use of experts. [Internet]. [cit\u00e9 19\u00a0d\u00e9c 2018]. Disponible sur: https:\/\/www.rand.org\/content\/dam\/rand\/pubs\/research_memoranda\/2009\/RM727.1.pdf."}],"container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450921000973?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450921000973?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T23:36:24Z","timestamp":1757720184000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003450921000973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0003450921000973"],"URL":"https:\/\/doi.org\/10.1016\/j.pharma.2021.07.003","relation":{},"ISSN":["0003-4509"],"issn-type":[{"type":"print","value":"0003-4509"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pratiques de curarisation\/d\u00e9curarisation et impact des modalit\u00e9s de d\u00e9curarisation sur les dur\u00e9es en salle op\u00e9ratoire et SSPI\u00a0\u2013\u00a0r\u00e9sultats d\u2019une enqu\u00eate Delphi","name":"articletitle","label":"Article Title"},{"value":"Annales Pharmaceutiques Fran\u00e7aises","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharma.2021.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Masson SAS on behalf of Acad\u00e9mie Nationale de Pharmacie.","name":"copyright","label":"Copyright"}]}}